NEWS
Combining strengths
Mitsubishi Electric further bolsters presence in Turkish market
M
itsubishi Electric Corporation has announced that its local subsidiary Mitsubishi Electric Turkey AŞ has completed the integration of its former air conditioning distributor Klima Plus, acquired earlier this year. The move will strengthen Mitsubishi Electric’s market share in the region as the business evolves to fully incorporate Klima Plus into the fold. As of June 2014, Mitsubishi Electric Turkey now comprises of two business units, the Factory Automation Systems business and the Air Conditioning business with a projected annual turnover of approximately 270 million Turkish Lira in 2015.
Masahiro Fujisawa, president, Mitsubishi Electric Turkey comments: “The completion of the Klima Plus integration is a great step forward for us, providing us with additional opportunities in the market. We have experienced strong growth over the last year and this will serve to further strengthen our position as well as affirm our commitment to the region.” Mitsubishi Electric’s existing infrastructure related businesses already available in the Turkish market such as satellites, lifts, escalators, transportation and power systems are all set to benefit. Visit: www.mitsubishielectric.com.tr
Saab completes Roche to acquire Santaris Pharma has agreed to acquire Santaris Pharma, expertise with Roche’s deep experience in disease acquisition of TKMS AB Roche a privately held biopharmaceutical company biology, chemistry, drug safety, drug formulation,
D
efence and security company Saab’s acquisition of the Swedish shipyard Thyssen Krupp Marine Systems AB (TKMS AB formerly Kockums) has now been completed. The acquisition strengthens Saab’s position as a comprehensive supplier of naval military systems. The company will become a business unit within Saab’s business area Security and Defence Solutions. The business unit is named Saab Kockums. Saab expects that operations will continue to be carried out primarily in Malmö, Karlskrona and Muskö. “The acquisition is in line with our strategy to expand our offering and strengthen Saab’s position in the market for naval systems. Kockums has a unique offering and a strong local presence in Sweden concerning submarines and warships. We also see good potential to expand the company’s current market position through opportunities in the export market,” says Håkan Buskhe, president and CEO of Saab. Visit: www.saabgroup.com
Molex announces completion of Flamar Cavi Elettrici acquisition
M
olex Incorporated, a global manufacturer of complete interconnect solutions, has announced that the previously announced acquisition of Flamar Cavi Elettrici Srl has closed. Italian-based cable manufacturer Flamar specialises in the design of custom cables for industrial
18 Industry Europe
based near Copenhagen, Denmark. Santaris Pharma has pioneered its proprietary Locked Nucleic Acid (LNA) platform that has contributed to an emerging era of RNA-targeting therapeutics. This new class of medicines has the potential to address difficult to treat diseases in a range of therapeutic areas. “Today there are many disease targets that are very challenging or even impossible to reach with small molecules or antibodies,” said John C. Reed, head of Roche Pharma Research and Early Development. “We believe the LNA platform provides the means to efficiently discover and develop an important new class of medicines that may address the significant needs of patients across multiple therapeutic areas.” “Roche and Santaris Pharma have complementary capabilities that will help us realise breakthrough medicines,” stated J. Donald deBethizy, president and CEO of Santaris Pharma. “The acquisition combines Santaris Pharma’s next-generation antisense technology and LNA
connectivity applications. Flamar will now operate as a subsidiary of Molex Incorporated. Terms were not disclosed. Italian-based Flamar Cavi Elettrici specialises in custom cables from design to finished product. Flamar high performance cables are deployed in industrial, automation, robotics, broadcast audio/video, and telecommunications applications.
delivery, and development.” Roche plans to maintain Santaris Pharma’s operations in Denmark, where the existing site will be renamed Roche Innovation Center Copenhagen. Visit: www.roche.com
Providing more than connectors, Molex delivers complete interconnect solutions for a number of markets including: data communications, telecommunications, consumer electronics, industrial, automotive, commercial vehicle, aerospace and defence, medical and lighting. Visit: www.molex.com
